Medical Weight Loss for Fargo, North Dakota Residents
Fargo, North Dakota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Fargo through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Fargo Residents Choose New Hope Weight Loss
Fargo patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across North Dakota and beyond since 2020.
Fargo patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
Patients across Fargo and the surrounding area connect with Dr. Sharma by secure video, wherever they live in North Dakota. We care for patients throughout Downtown, North Fargo, South Fargo, West Fargo, and the Fargo-Moorhead area. There is no distance surcharge for Fargo patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Telehealth removes the distance between Fargo and specialized care: your consultation happens wherever you are in North Dakota. The first step is a $119 physician review; if you are not a candidate you are not charged, and compounded semaglutide starts at $166/month.
GLP-1 Weight Loss Programs Available
Compounded semaglutide, from $166/mo (90-day program $499)
The 90-day Metabolic Reset is our most-chosen plan. Semaglutide shares its active ingredient with Wegovy® and Ozempic®; in trials of the branded drug, patients lost an average of 15-17% of body weight under physician supervision.
Compounded tirzepatide, from $233/mo
Tirzepatide's dual GLP-1/GIP action reached up to 22.5% body-weight loss in trials of the branded medication, the advanced option for Fargo patients.
The physician review is a flat $119, with medication billed separately; HSA, FSA, Klarna, and Affirm are accepted.
How Telehealth Works for Fargo
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Fargo address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Fargo
How do I get treatment from Fargo?
As a Fargo, North Dakota patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Fargo?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Fargo in cold-pack packaging, no lines and no drive.
How much does it cost for Fargo patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Fargo do you serve?
We serve patients from across Fargo by telehealth, including Downtown, North Fargo, South Fargo, West Fargo, and the Fargo-Moorhead area.
What does treatment cost for Fargo patients?
The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Fargo.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Fargo, North Dakota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.